WP7-SG3 guideline on “Therapeutic medical devices” is now available.
We are happy to announce that the final guideline on “Therapeutic medical devices” is now available. This document is the guideline on “Therapeutic medical devices”, with answered comments, produced by WP7’s Subgroup 3, and it is the final guideline from WP7-SG3 in JA2. Find this guideline and its results here.
The 6th pilot rapid assessment of WP5 JA2 Strand B on “Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke” is now available
We are pleased to announce that the 6th pilot rapid assessment of WP5 JA2 Strand B on “Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke” is available. This assessment examines the effectiveness and safety of mechanical thrombectomy in adults aged 18 years or older with acute ischaemic stroke in the anterior and/or posterior […]
[CLOSED] Public Consultation for EUnetHTA JA2 WorkPackage4 Core HTA no.3
We are happy to announce that the third Core HTA produced within the EUnetHTA Joint Action 2 Work Package 4 is available for public feedback. The topic assessed is “Structured telephone support (STS) for adult patients with chronic heart failure” This consultation will take place between November 10th and November 26th, 2015. Objective of public […]
[CLOSED] Public Consultation for EUnetHTA JA2 WorkPackage4 Core HTA no.3
We are happy to announce that the third Core HTA produced within the EUnetHTA Joint Action 2 Work Package 4 is available for public feedback. The topic assessed is “Structured telephone support (STS) for adult patients with chronic heart failure” This consultation will take place between November 10th and November 26th, 2015. Objective of public […]
HTA is high on the European agenda for action
With the preparation of the Joint Action 3 on HTA switching into high gear, confirmation of the immediate practical relevance of the HTA activities are coming in – both from the national and larger European level events of the recent days. With the preparation of the Joint Action 3 on HTA switching into high gear, confirmation of […]
EUnetHTA Joint Action 3 – formal preparatory work starting
The first formal meeting in preparation of the Joint Action 3 on HTA (as put forward in the 2015 Work Programme of the EU Health Programme) took place on October 15, 2015 in Brussels The first formal meeting in preparation of the Joint Action 3 on HTA (as put forward in the 2015 Work Programme of […]
EUnetHTA at ISPOR Milan, November 7-11, 2015
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is expecting as many as 5000 participants in its 18th Annual European Congress in Milan, Italy. EUnetHTA is organising two issue panels at the upcoming ISPOR Annual European Congress: Quality-adjusted life years (QALYs) – Help or hindrance in supporting health care decision making Moderator: Emelie Maria […]
[CLOSED] Public consultation of the adapted methodological guideline “Endpoints used in Relative Effectiveness Assessment – Safety”
We are pleased to announce that as of today, 21 October, 2015, the methodological guideline “Endpoints used in Relative Effectiveness Assessment – Safety”, originally published in March 2013 and now adapted within WP7 – Subgroup 3, has entered the public consultation phase. This consultation will take place between 21 October and 17 November 2015. Objective […]
[CLOSED] Public consultation of Draft Assessment Report of the sixth pilot of WP5 Strand A: Rapid Relative Effectiveness Assessment of new pharmaceuticals for the treatment of chronic hepatitis C
We are pleased to announce that as of today, 15 October, the Second Draft Report focusing on the production of a Rapid Relative Effectiveness Assessment of new pharmaceuticals for the treatment of chronic hepatitis C by Work Package 5, Strand A has entered the public consultation phase. This consultation phase will take place between 15 […]
[CLOSED] Public consultation of the draft methodological guideline “Therapeutic medical devices”
We are pleased to announce that as of today, 14 October, 2015, the draft methodological guideline “Therapeutic medical devices”, produced within WP7 – Subgroup 3, has entered the public consultation phase. This consultation will take place between 14 October and 11 November 2015. Objective of the methodological guideline EUnetHTA´s methodological guidelines are targeted to the […]
